These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7989386)

  • 1. Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin.
    Faunø P; Suomalainen O; Rehnberg V; Hansen TB; Krøner K; Soimakallio S; Nielsen E
    J Bone Joint Surg Am; 1994 Dec; 76(12):1814-8. PubMed ID: 7989386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
    J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
    Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
    J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial.
    Warwick D; Harrison J; Glew D; Mitchelmore A; Peters TJ; Donovan J
    J Bone Joint Surg Am; 1998 Aug; 80(8):1158-66. PubMed ID: 9730125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group.
    Br J Surg; 1997 Aug; 84(8):1099-103. PubMed ID: 9278651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
    Eriksson BI; Ekman S; Lindbratt S; Baur M; Bach D; Torholm C; Kälebo P; Close P
    J Bone Joint Surg Am; 1997 Mar; 79(3):326-33. PubMed ID: 9070519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
    Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G
    N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group.
    J Bone Joint Surg Am; 1994 Aug; 76(8):1174-85. PubMed ID: 8056798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Stephens JW; Gardiner GA; Ritter MA
    Clin Orthop Relat Res; 1995 Dec; (321):19-27. PubMed ID: 7497668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty.
    Colwell CW; Spiro TE
    Clin Orthop Relat Res; 1995 Oct; (319):215-22. PubMed ID: 7554633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial.
    McLeod RS; Geerts WH; Sniderman KW; Greenwood C; Gregoire RC; Taylor BM; Silverman RE; Atkinson KG; Burnstein M; Marshall JC; Burul CJ; Anderson DR; Ross T; Wilson SR; Barton P;
    Ann Surg; 2001 Mar; 233(3):438-44. PubMed ID: 11224634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: a co-operative study.
    Kakkar VV; Murray WJ
    Br J Surg; 1985 Oct; 72(10):786-91. PubMed ID: 3899240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.
    Sherman DG; Albers GW; Bladin C; Fieschi C; Gabbai AA; Kase CS; O'Riordan W; Pineo GF;
    Lancet; 2007 Apr; 369(9570):1347-1355. PubMed ID: 17448820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.
    Geerts WH; Jay RM; Code KI; Chen E; Szalai JP; Saibil EA; Hamilton PA
    N Engl J Med; 1996 Sep; 335(10):701-7. PubMed ID: 8703169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery.
    Koppenhagen K; Adolf J; Matthes M; Tröster E; Roder JD; Hass S; Fritsche HM; Wolf H
    Thromb Haemost; 1992 Jun; 67(6):627-30. PubMed ID: 1324534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
    Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
    Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery.
    Levine MN; Gent M; Hirsh J; Weitz J; Turpie AG; Powers P; Neemeh J; Willan A; Skingley P
    Arch Intern Med; 1996 Apr; 156(8):851-6. PubMed ID: 8774203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trial.
    Navarro-Quilis A; Castellet E; Rocha E; Paz-Jiménez J; Planès A;
    J Thromb Haemost; 2003 Mar; 1(3):425-32. PubMed ID: 12871445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.